Back to results
US 2021/0260077 A1Published application
Oral solutions comprising fludrocortisone acetate
AssigneeLabomed Pharmaceutical Company S.A.
InventorsGeorgios LIOLIOS, Tsampikos Dimitrios PANAGIOTOPOULOS, Konstantinos PACHIS
Life of this patent
Estimating the term…
Abstract
Physicochemically stable oral pharmaceutical solution comprising fludrocortisone acetate and a non-aqueous liquid carrier comprising one or more medium-chain fatty acid triglycerides.
Claims14
Oral pharmaceutical solution comprising from 0.001% w/v to 0.01% w/v fludrocortisone acetate and a non-aqueous liquid carrier comprising one or more triglycerides of saturated fatty acids having an aliphatic chain of 6 to 10 carbon atoms (medium-chain triglycerides), wherein the total concentration of medium-chain triglycerides in the oral solution is at least 45% w/v.
Dependencies are inferred from the claim text.